Financhill
Back

Freeport-McMoRan Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
68

FCX
Freeport-McMoRan

Last Price:
$45.81
Seasonality Move:
0.51%
Sell
43

SRPT
Sarepta Therapeutics

Last Price:
$18.22
Seasonality Move:
20.21%
Buy
68
Freeport-McMoRan (FCX) is a Buy

Is Freeport-McMoRan a Buy, Sell or Hold?

  • The current Freeport-McMoRan [FCX] share price is $45.77. The Score for FCX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • FCX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $18.20. The Score for SRPT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FCX Stock Price Chart

What is Freeport-McMoRan's stock price today?

  • The Freeport-McMoRan share price today is $45.77
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $18.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

FCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.35 Buy
Relative Strength Index (14 RSI): 69.34 Buy
Chaikin Money Flow: 4399445 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.87 - 43.27) Buy
Bollinger Bands (100): (35.17 - 41.41) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.63 Sell
Relative Strength Index (14 RSI): 22.9 Sell
Chaikin Money Flow: 2644712 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.11 - 39.13) Sell
Bollinger Bands (100): (31.38 - 92.06) Sell

FCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.26 Buy
20-day SMA: 42.12 Buy
50-day SMA: 39.62 Buy
200-day SMA: 40.82 Buy
8-day EMA: 43.58 Buy
20-day EMA: 42.16 Buy
50-day EMA: 40.29 Buy
200-day EMA: 40.36 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.83 Buy
20-day SMA: 26.89 Sell
50-day SMA: 38.26 Sell
200-day SMA: 91.97 Sell
8-day EMA: 18.98 Sell
20-day EMA: 24.85 Sell
50-day EMA: 37.93 Sell
200-day EMA: 79.67 Sell

Freeport-McMoRan Earnings Growth & FCX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.03 per share, an increase this year of $0.25 per share, and an increase next year of $0.54 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.75 per share, a decrease this year of $5.88 per share, and an increase next year of $5.33 per share.

Freeport-McMoRan Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):